Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC

被引:64
作者
Gorman, CM
Aikawa, M
Fox, B
Fox, E
Lapuz, C
Michaud, B
Nguyen, H
Roche, E
Sawa, T
WienerKronish, JP
机构
[1] MEGABIOS CORP,BURLINGAME,CA
[2] UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIA & CRIT CARE,SAN FRANCISCO,CA 94143
关键词
intralobal delivery; cationic lipid; CFTR; non-viral vector; EDMPC;
D O I
10.1038/sj.gt.3300473
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We compared the efficacy of gene transfer in vitro and in vivo using various formulations of DNA-lipid complexes based on the novel cationic lipid EDMPC (1,2-dimyristoylsn-glycero-3-ethylphosphocholine, chloride salt). In vitro studies analyzed delivery of marker genes to four established cells lines, including two of pulmonary origin. The in vivo analysis used intralobar delivery of marker genes and CFTR to mice and rats. We observed a lack of positive correlation between those DNA-EDMPC formulations that delivered DNA most efficiently in vitro and those that worked best in vivo. Intralobar DNA delivery to rodents mediated by EDMPC was efficient. The high level of gene delivery by DNA-EDMPC formulations demonstrates that efficient lipid-mediated gene transfer to the lung is possible.
引用
收藏
页码:983 / 992
页数:10
相关论文
共 34 条
[1]   NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE [J].
ALTON, EWFW ;
MIDDLETON, PG ;
CAPLEN, NJ ;
SMITH, SN ;
STEEL, DM ;
MUNKONGE, FM ;
JEFFERY, PK ;
GEDDES, DM ;
HART, SL ;
WILLIAMSON, R ;
FASOLD, KI ;
MILLER, AD ;
DICKINSON, P ;
STEVENSON, BJ ;
MCLACHLAN, G ;
DORIN, JR ;
PORTEOUS, DJ .
NATURE GENETICS, 1993, 5 (02) :135-142
[2]  
BANKSTON PW, 1991, EUR J CELL BIOL, V54, P187
[3]   CHOLESTEROL ENHANCES CATIONIC LIPOSOME-MEDIATED DNA TRANSFECTION OF HUMAN RESPIRATORY EPITHELIAL-CELLS [J].
BENNETT, MJ ;
NANTZ, MH ;
BALASUBRAMANIAM, RP ;
GRUENERT, DC ;
MALONE, RW .
BIOSCIENCE REPORTS, 1995, 15 (01) :47-53
[4]   A VERY STRONG ENHANCER IS LOCATED UPSTREAM OF AN IMMEDIATE EARLY GENE OF HUMAN CYTOMEGALO-VIRUS [J].
BOSHART, M ;
WEBER, F ;
JAHN, G ;
DORSCHHASLER, K ;
FLECKENSTEIN, B ;
SCHAFFNER, W .
CELL, 1985, 41 (02) :521-530
[5]   Current status of CF gene therapy [J].
Boucher, RC .
TRENDS IN GENETICS, 1996, 12 (03) :81-84
[6]  
CANONICO AE, 1994, AM J RESP CELL MOL B, V10, P22
[7]  
CAPLEN NJ, 1994, GENE THER, V1, P139
[8]  
CAPLEN NJ, 1995, GENE THER, V2, P603
[9]  
Crook K, 1996, GENE THER, V3, P834
[10]   TRANSACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS OCCURS VIA A BIMODAL MECHANISM [J].
CULLEN, BR .
CELL, 1986, 46 (07) :973-982